Current and evolving management of subarachnoid hemorrhage

Area of Science:

• Neurology
• Neurosurgery
• Critical Care Medicine

Background:

• Subarachnoid hemorrhage (SAH) is a devastating neurological event with high mortality (25-50%) and significant long-term disability.
• Aneurysmal rupture, a primary cause of SAH, affects approximately 30,000 individuals annually in the US, accounting for 2-5% of all strokes.
• Unlike other stroke types, SAH incidence remains stable, and up to 46% of survivors experience cognitive impairment, impacting quality of life.

Purpose of the Study:

• To highlight the critical nature of aneurysmal subarachnoid hemorrhage (SAH).
• To underscore the persistent incidence and severe consequences of SAH.
• To emphasize the role of modern therapeutic strategies in mitigating SAH-related morbidity.

Main Methods:

• Review of epidemiological data on SAH incidence and mortality.
• Analysis of the long-term cognitive and functional outcomes in SAH survivors.
• Discussion of current therapeutic approaches for managing SAH and preventing secondary injury.

Main Results:

• SAH exhibits a high mortality rate, with a substantial percentage of deaths occurring pre-hospital.
• Aneurysmal SAH represents a significant proportion of strokes, with no decline in incidence.
• Long-term cognitive impairment is prevalent among SAH survivors, affecting functional status.

Conclusions:

• Aneurysmal rupture is a life-altering event with profound implications for survivors.
• Modern therapeutic interventions are crucial for reducing secondary brain injury and preventing re-bleeding.
• Effective management strategies are essential to improve outcomes and quality of life for SAH patients.